Bayer & J&J Reach Settlement to Resolve Xarelto Litigation
Resilinc-blog

According to Reuters, Bayer AG and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, have agreed to pay $775 million to settle more than 25,000 lawsuits over their blood-thinning drug Xarelto, as reported on Monday, March 25.

Read All Global Disruptions

Recent Global Disruptions